Walleye Capital’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Walleye Capital’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,205	Closed	-$212K	–	3837
2022 Q3	$212K	Hold	21,205	–	–	﹤0.01%	2071
2022 Q2	$209K	Hold	21,205	–	–	0.01%	1504
2022 Q1	$209K	Sell	21,205 -795	-4%	-$7.8K	0.01%	1503
2021 Q4	$214K	Buy	+22,000	New	+$215K	0.01%	1433

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Walleye Capital's PKBO Position: Q4 2022 in Review

Walleye Capital sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 21,205 shares — an estimated $212K sold.

Walleye Capital first reported a position in PKBO in Q4 2021 and held it in 4 quarters. The position peaked at $214K in Q4 2021. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Walleye Capital reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 21,205 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $212K.
Walleye Capital first reported a position in Peak Bio, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Walleye Capital's Peak Bio, Inc. Common Stock position peaked at $214K in Q4 2021.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.